NCT07159204View on ClinicalTrials.gov

Paclitaxel mIcelle Later-line cOmbined immunoTherapy for Biliary Tract Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

July 1, 2026

Conditions

Biliary Tract Cancer (BTC)

Interventions

DRUG

Paclitaxel polymer micelle immunocombination

Paclitaxel polymer micelle immunocombination

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER